Hiring spree to grow team by 75%

Posted 30 January 2025 AM

Boehringer is embarking on its largest recruitment drive in more than a decade with the aim of growing its medical representative field force by 75 per cent to accelerate the growth of its cardio-renal-metabolism (CRM) portfolio.

There are more than 50 sales rep roles across Australia up for grabs with the hiring spree spearheaded by heart failure drug Jardiance and diabetes medication Trajenta. The company said it's "investing for short, mid and long-term growth" thanks to a burgeoning pipeline.

To see the whole article, please login